...
首页> 外文期刊>The journal of obstetrics and gynaecology research >Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
【24h】

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

机译:日本妇产科学会妇科肿瘤学委员会年度报告

获取原文
获取原文并翻译 | 示例
           

摘要

The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Treatment Annual Report for 2007. Data on the prognosis of 3381 patients with cervical cancer, 3681 with endometrial cancer, and 2367 with ovarian cancer for whom treatment was initiated in 2007 were analyzed in the Treatment Annual Report. In the 2007 Treatment Annual Report, stage I accounted for 53.1%, stage II for 24.4%, stage III for 14.2%, and stage IV for 8.3% of all patients with cervical cancer. Stage I accounted for 64.8%, stage II for 8.2%, stage III for 20.2%, and stage IV for 6.9% of all patients with endometrial cancer. Stage I accounted for 41.4%, stage II for 9.9%, stage III for 30.6%, and stage IV for 8.6% of all patients with ovarian cancer.
机译:日本妇产科学会从会员机构收集和分析有关妇科癌症的年度数据。在这里,我们提供了2007年治疗年度报告。2007年开始治疗的3381例宫颈癌,3681例子宫内膜癌和2367例卵巢癌患者的预后数据进行了分析。在2007年治疗年度报告中,在所有子宫颈癌患者中,第一阶段占53.1%,第二阶段占24.4%,第三阶段占14.2%,第四阶段占8.3%。在所有子宫内膜癌患者中,第一阶段占64.8%,第二阶段占8.2%,第三阶段占20.2%,第四阶段占6.9%。在所有卵巢癌患者中,I期占41.4%,II期占9.9%,III期占30.6%,IV期占8.6%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号